| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Lachey Jennifer is a Chief Scientific Officer at Keros Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 26 sells.
Estimated insider holdings value: $1.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2022 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 46,034 | $30.00 | $1,381,020.00 | -32.6% | +50.1% | +33.0% | |
| Jul 13, 2022 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,916 | $30.00 | $57,480.00 | -2.0% | +41.6% | +34.7% | |
| May 11, 2022 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 5,300 | $41.90 | $222,049.61 | -1.2% | -11.9% | +6.8% | |
| Apr 11, 2022 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 5,300 | $62.77 | $332,704.52 | -1.5% | -55.1% | -39.8% | |
| Apr 4, 2022 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 7,950 | $60.00 | $477,000.00 | -8.5% | -54.2% | -33.5% | |
| Mar 11, 2022 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,650 | $53.38 | $141,448.84 | -1.0% | -40.4% | -14.5% | |
| Feb 11, 2022 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,650 | $52.06 | $137,964.70 | -1.0% | -19.4% | +4.0% | |
| Jan 11, 2022 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,650 | $53.75 | $142,447.26 | -1.0% | +14.3% | -11.7% | |
| Jan 5, 2022 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,650 | $60.00 | $159,000.00 | -3.0% | +12.3% | -18.8% | |
| Dec 15, 2021 | KROS Keros Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,650 | $50.40 | $133,558.26 | -0.8% | -2.7% | -4.9% |